[Non A-G chronic hepatitis in Japan]

Area of Science:

• Hepatology
• Virology
• Epidemiology

Background:

• Viral hepatitis encompasses types A through E, but some patients remain seronegative.
• Hepatitis G virus (HGV) is a recently discovered virus with a debated role in liver disease.
• Epidemiological data on chronic hepatitis cases negative for known hepatitis viruses (A-G) in Japan is limited.

Purpose of the Study:

• To investigate the prevalence and characteristics of non-A to G chronic hepatitis in Japanese patients.
• To identify potential risk factors and disease progression in patients with unknown hepatitis agents.
• To compare liver enzyme levels in non-A to G hepatitis patients with those of known hepatitis types.

Main Methods:

• Retrospective analysis of 1089 patients with chronic liver disease in Japan.
• Serological testing for hepatitis A, B, C, D, and E, along with Hepatitis B surface antigen (HbsAg), Hepatitis C antibody (HCV-Ab), and Hepatitis G virus RNA (HGV RNA).
• Classification of patients into non-A to G hepatitis based on negative results for all tested markers.

Main Results:

• Twenty-five patients (1.8%) were diagnosed with non-A to G hepatitis, including chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
• Only 3 of these patients had a history of blood transfusion.
• Transaminase levels in non-A to G hepatitis patients (without hepatocellular carcinoma) were comparable to those with chronic hepatitis B and C.

Conclusions:

• Non-A to G chronic hepatitis has a low prevalence in Japan but can progress to advanced liver disease.
• The findings suggest the existence of unknown etiological agents responsible for non-A to G hepatitis.
• Further research is needed to identify these unknown agents and understand their role in liver disease pathogenesis.